UK markets closed

Qualigen Therapeutics, Inc. (7R9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1190-0.0090 (-7.03%)
At close: 08:12AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/03/2020
Cash flows from operating activities
Net income
-13,417
-13,417
-18,641
-17,897
-1,788
Depreciation & amortisation
4.495
4.495
12.165
338.277
216.602
Stock-based compensation
1,099
1,099
4,765
5,294
7.866
Change in working capital
1,112
1,112
-642.866
2,213
1,522
Accounts receivable
-
-
417.708
41.25
129.341
Inventory
-
-
-637.41
111.422
57.917
Accounts payable
1,603
1,603
-43.44
385.455
482.173
Other working capital
-10,304
-10,304
-13,248
-14,872
-137.146
Other non-cash items
2,547
2,547
-
101.75
20.834
Net cash provided by operating activities
-10,304
-10,304
-13,248
-14,731
57.331
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-319.117
-141.364
-194.477
Net cash used for investing activities
4,216
4,216
-183.763
-141.364
-194.477
Cash flows from financing activities
Debt repayment
-550
-550
0
-138.739
-165.921
Common stock issued
-
-
0
8,820
0
Common stock repurchased
0
0
-0.505
0
-
Other financing activities
-
-
-
-706.929
-
Net cash used provided by (used for) financing activities
-550
-550
2,911
8,434
165.144
Net change in cash
-6,638
-6,638
-10,521
-6,438
27.998
Cash at beginning of period
7,040
7,040
17,538
23,977
125.123
Cash at end of period
401.803
401.803
3,166
17,538
153.121
Free cash flow
Operating cash flow
-10,304
-10,304
-13,248
-14,731
57.331
Capital expenditure
-
-
-319.117
-141.364
-194.477
Free cash flow
-10,304
-10,304
-13,248
-14,872
-137.146